| Trial Identifier: | D589CC00014 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02533505 |
| Start Date: | August 2015 |
| Primary Completion Date: | August 2016 |
| Study Completion Date: | August 2016 |
| Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation |
| Country | Location |
|---|---|
| United States of America, CT | Hartford, CT, United States of America, 06105 |
| United States of America, MA | Boston, MA, United States of America, 02115 |
| United States of America, NC | Charlotte, NC, United States of America, 28207 |
| United States of America, OH | Cincinnati, OH, United States of America, 45267 |
| United States of America, PA | Philadelphia, PA, United States of America, 19140 |
| United States of America, SC | Spartanburg, SC, United States of America, 29303 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company